163 related articles for article (PubMed ID: 24618613)
1. Well-differentiated papillary mesothelioma with invasive foci.
Churg A; Allen T; Borczuk AC; Cagle PT; Galateau-Sallé F; Hwang H; Murer B; Murty VV; Ordonez N; Tazelaar HD; Wick M
Am J Surg Pathol; 2014 Jul; 38(7):990-8. PubMed ID: 24618613
[TBL] [Abstract][Full Text] [Related]
2. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.
Lee HE; Molina JR; Sukov WR; Roden AC; Yi ES
Hum Pathol; 2018 Sep; 79():168-176. PubMed ID: 29763720
[TBL] [Abstract][Full Text] [Related]
3. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
4. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
5. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
Chirac P; Maillet D; Leprêtre F; Isaac S; Glehen O; Figeac M; Villeneuve L; Péron J; Gibson F; Galateau-Sallé F; Gilly FN; Brevet M
Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
[TBL] [Abstract][Full Text] [Related]
6. A Case of Solitary Well-Differentiated Papillary Mesothelioma with Invasive Foci in the Pleura.
Shimizu S; Yoon HE; Ito N; Tsuji T; Funakoshi Y; Utsumi T; Sakaguchi M; Tsujimura T; Kasai T; Hiroshima K; Matsumura A
Pathol Int; 2017 Jan; 67(1):45-49. PubMed ID: 27886416
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
Xing D; Banet N; Sharma R; Vang R; Ronnett BM; Illei PB
Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740
[TBL] [Abstract][Full Text] [Related]
8. Histological and immunohistochemical characteristics and
Fujishima F; Konosu-Fukaya S; Nabeshima K; McNamara KM; Sakamoto K; Sakurada J; Sasano H; Nakamura Y
Indian J Pathol Microbiol; 2021; 64(2):277-281. PubMed ID: 33851620
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics of Well-differentiated Papillary Mesothelioma of The Peritoneum: A Single-institutional Experience of 12 Cases.
Kim M; Kim HS
In Vivo; 2019; 33(2):633-642. PubMed ID: 30804152
[TBL] [Abstract][Full Text] [Related]
10. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T
Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374
[TBL] [Abstract][Full Text] [Related]
11. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients.
Liu S; Staats P; Lee M; Alexander HR; Burke AP
Pathology; 2014 Dec; 46(7):604-9. PubMed ID: 25393250
[TBL] [Abstract][Full Text] [Related]
12. Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature.
Del Gobbo A; Fiori S; Gaudioso G; Bonaparte E; Tabano S; Palleschi A; Bosari S; Ferrero S
Int J Clin Exp Pathol; 2014; 7(5):2484-9. PubMed ID: 24966960
[TBL] [Abstract][Full Text] [Related]
13. IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma.
Hui S; Guo-Qi Z; Xiao-Zhong G; Chun-Rong L; Yu-Fei L; Dong-Liang Y
Hum Pathol; 2018 Nov; 81():138-147. PubMed ID: 30031101
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
Pavlisko EN; Roggli VL
Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
[TBL] [Abstract][Full Text] [Related]
15. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
Goldblum J; Hart WR
Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.
Lee YK; Jun HJ; Nahm JH; Lim TS; Park JS; Ahn JB; Rha SY; Chung HC; Oh HE; Song JS; Yang WI; Kim HS
Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112
[TBL] [Abstract][Full Text] [Related]
17. [Digestive tumors and pseudotumors that rarely get discussed. Case 4: malignant mesothelioma of the peritoneum].
Galateau-Sallé F
Ann Pathol; 2013 Aug; 33(4):263-9. PubMed ID: 23954121
[No Abstract] [Full Text] [Related]
18. Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor.
Galateau-Salle F; Hamilton T; MacNeill A; Hofman V; Sequeiros R; Sagan C; Le Stang N; Churg A
Am J Surg Pathol; 2023 May; 47(5):611-617. PubMed ID: 36876759
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation.
Chen X; Sheng W; Wang J
Histopathology; 2013 Apr; 62(5):805-13. PubMed ID: 23530588
[TBL] [Abstract][Full Text] [Related]
20. PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
Chapel DB; Husain AN; Krausz T; McGregor SM
Am J Surg Pathol; 2017 Dec; 41(12):1675-1682. PubMed ID: 28877056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
